000 01335 a2200409 4500
005 20250514001311.0
264 0 _c20010614
008 200106s 0 0 eng d
022 _a0006-2952
024 7 _a10.1016/s0006-2952(01)00630-x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBillack, B
245 0 0 _aMinimal amidine structure for inhibition of nitric oxide biosynthesis.
_h[electronic resource]
260 _bBiochemical pharmacology
_cJun 2001
300 _a1581-6 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAmidines
_xchemistry
650 0 4 _aAnimals
650 0 4 _aCells, Cultured
650 0 4 _aGuanidines
_xchemistry
650 0 4 _aHumans
650 0 4 _aMice
650 0 4 _aNitric Oxide
_xmetabolism
650 0 4 _aNitric Oxide Synthase
_xdrug effects
650 0 4 _aNitric Oxide Synthase Type II
650 0 4 _aRats
650 0 4 _aStructure-Activity Relationship
700 1 _aHeck, D E
700 1 _aPorterfield, D M
700 1 _aMalchow, R P
700 1 _aSmith, P J
700 1 _aGardner, C R
700 1 _aLaskin, D L
700 1 _aLaskin, J D
773 0 _tBiochemical pharmacology
_gvol. 61
_gno. 12
_gp. 1581-6
856 4 0 _uhttps://doi.org/10.1016/s0006-2952(01)00630-x
_zAvailable from publisher's website
999 _c11308904
_d11308904